home / stock / snynf / snynf short
Short Information | Sanofi (OTCMKTS:SNYNF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,697 |
Total Actual Volume | 66,634 |
Short Trends | |
---|---|
Cover Days | 16 |
Short Days | 3 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 85 |
Average Short Percentage | 17.82% |
Is there a SNYNF Short Squeeze or Breakout about to happen?
See the SNYNF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-01-2024 | $0 | $95.5 | $0 | $0 | 50 | 25 | 50% |
06-27-2024 | $0 | $95.5 | $0 | $0 | 695 | 7 | 1.01% |
06-26-2024 | $94.864 | $95.5 | $95.5 | $94.864 | 412 | 137 | 33.25% |
06-25-2024 | $95.8 | $96 | $96 | $94.56 | 1,586 | 4 | 0.25% |
06-24-2024 | $96.578 | $96.1044 | $96.578 | $94.5 | 892 | 26 | 2.91% |
06-21-2024 | $95.28 | $95.28 | $95.28 | $95.28 | 286 | 105 | 36.71% |
06-20-2024 | $92.546 | $92.546 | $92.546 | $92.546 | 544 | 66 | 12.13% |
06-18-2024 | $92.63 | $96.364 | $96.45 | $92.63 | 559 | 309 | 55.28% |
06-17-2024 | $94.11 | $94.11 | $94.11 | $94.11 | 882 | 16 | 1.81% |
06-14-2024 | $95.75 | $93.035 | $95.75 | $93 | 1,492 | 185 | 12.4% |
06-13-2024 | $0 | $96.0825 | $0 | $0 | 50,002 | 2 | 0% |
06-11-2024 | $0 | $96.0825 | $0 | $0 | 17 | 3 | 17.65% |
06-10-2024 | $96.7677 | $96.0825 | $96.7677 | $94.678 | 1,778 | 514 | 28.91% |
06-07-2024 | $0 | $97.48 | $0 | $0 | 18 | 10 | 55.56% |
06-06-2024 | $0 | $97.48 | $0 | $0 | 154 | 3 | 1.95% |
06-05-2024 | $97.48 | $97.48 | $97.48 | $97.48 | 998 | 4 | 0.4% |
06-04-2024 | $98.05 | $98.26 | $98.26 | $98.05 | 1,300 | 218 | 16.77% |
06-03-2024 | $96.25 | $95.47 | $96.4775 | $95.47 | 3,579 | 24 | 0.67% |
05-31-2024 | $0 | $94.63 | $0 | $0 | 52 | 14 | 26.92% |
05-30-2024 | $94.63 | $94.63 | $94.63 | $94.63 | 1,338 | 25 | 1.87% |
News, Short Squeeze, Breakout and More Instantly...
Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Paris, June 21, 2024 . Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France’s President, has been named Executive Vice President, Global Head ...
ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Seven oral presentations across the hemophilia portfolio reinforce Sanofi’s commitment to bring potential first- and best-in-class treatments to the rare blood disorders community Interim r...
Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa Paris, June 20, 2024. Sanofi and Biovac, a Cape Town, South Africa-based biopharmaceutical company, announce today their local manufacturing partnership to produce inactivated polio vaccines (IPV) in Africa. ...